Return to program book search
Case-Based Controversies in Blistering Diseases
Ticket required for admission, no tuition fee. Ticket holds seat for only 15 minutes after the official start time.
Thursday, August 16
10:00 AM - 12:00 PM
Dedee F. Murrell, MD, FAAD - Handout
- Donna Culton, MD, PhD, FAAD - Handout
- Branka Marinovic, MD, PhD - Handout
Following this course, the attendee should be able to:
- Determine which tests need to be ordered to diagnose blistering diseases correctly.
- Develop algorithms for how to treat AIBD patients.
- Explain safety measures to patients to minimize complications.
Cases in which the diagnosis is initially unclear and further unusual investigations are needed to uncover the correct diagnosis will be discussed. Pemphigus vulgaris cases which were recalcitrant to high dose corticosteroids - what should we do? When should we choose rituximab? What about IVIG? Should you stop treatment if the ELISA titer is high but the patient appears to be in remission on minimal therapy? Does the patient have localized bullous pemphigoid even if the blisters on the lower leg are negative on direct IF?